05-18-2022, 03:59 PM
The EpiPen class action lawsuit began after Mylan, the makers of EpiPen, decided to raise the price of the two-pack of EpiPens from $100 to $600 in 2016. This hike in prices, along with the necessity to purchase new EpiPens every 12 to 18 months before they expired, meant that many consumers could no longer afford this life-saving device. The lawsuit alleged that consumers had been overcharged for each EpiPen purchased and, since 2011, had been forced to purchase the EpiPen 2-Pak every time they purchased an EpiPen. The defendants were able to do this because of their control of the epinephrine auto-injector market. According to the Consumer Proof of Claim form, in order to be eligible to file a claim form and receive a cash distribution from the settlement, the consumer must be a person who paid or provided reimbursement for some or all of the purchase price of branded EpiPen or EpiPen Jr. devices or authorized generic versions of EpiPen devices between August 24, 2011 and November 1, 2020. Consumers who purchased EpiPen refills are not included in the class because they were not affected by this alleged conspiracy. EpiPen refills are available for around $20 each and have been an affordable alternative to the climbing cost of the EpiPen.
Status: under further investigation
Status: under further investigation